Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Moderna
MRNA
|
$923M |
| 2 |
Amazon
AMZN
|
$813M |
| 3 |
Apple
AAPL
|
$809M |
| 4 |
Microsoft
MSFT
|
$775M |
| 5 |
Tesla
TSLA
|
$664M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
$258M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
$124M |
| 5 |
Oracle
ORCL
|
$124M |
Sector Composition
| 1 | Technology | 24.55% |
| 2 | Financials | 13.94% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4251
Bit Digital
BTBT
$784M
| $313K | ﹤0.01% |
43,370
+16,491
| +61% | +$119K |
|
4252
Reviva Pharmaceuticals
RVPH
$29.9M
| $313K | ﹤0.01% |
76,964
+9,240
| +14% | +$37.6K |
|
4253
Assertio
ASRT
$76.4M
| $311K | ﹤0.01% |
344,331
+7,525
| +2% | +$6.8K |
|
|
BITF
4254
Bitfarms
BITF
$685M
| $311K | ﹤0.01% |
73,196
| – | – |
|
|
ETTX
4255
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
| $311K | ﹤0.01% |
93,168
+12,047
| +15% | +$40.2K |
|
4256
Bakkt Holdings
BKKT
$119M
| $310K | ﹤0.01% |
1,230
+615
| +100% | +$155K |
|
4257
Cyclacel Pharmaceuticals
CYCC
$16.5M
| $310K | ﹤0.01% |
16
+2
| +14% | +$38.8K |
|
|
DCRC
4258
DELISTED
Decarbonization Plus Acquisition Corporation III Class A Common Stock
DCRC
| $308K | ﹤0.01% |
30,710
| – | – |
|
4259
Siebert Financial
SIEB
$101M
| $307K | ﹤0.01% |
91,913
-6,675
| -7% | -$22.3K |
|
4260
Lexaria Bioscience
LEXX
$19.4M
| $306K | ﹤0.01% |
49,002
-1,383
| -3% | -$8.64K |
|
4261
Mediaco Holding
MDIA
$69.8M
| $306K | ﹤0.01% |
26,326
+14,194
| +117% | +$165K |
|
4262
FlexShopper
FPAY
$18.2M
| $305K | ﹤0.01% |
98,289
+3,731
| +4% | +$11.6K |
|
4263
Evoke Pharma
EVOK
$8.18M
| $304K | ﹤0.01% |
1,627
+268
| +20% | +$50.1K |
|
4264
Data I/O
DAIO
$29.7M
| $303K | ﹤0.01% |
46,621
+4,118
| +10% | +$26.8K |
|
4265
ProQR Therapeutics
PRQR
$251M
| $303K | ﹤0.01% |
36,293
+10,888
| +43% | +$90.9K |
|
4266
Houston American Energy
HUSA
$252M
| $301K | ﹤0.01% |
13,211
+10,226
| +343% | +$233K |
|
4267
Sonnet BioTherapeutics
SONN
$19M
| $301K | ﹤0.01% |
202
+196
| +3,267% | +$292K |
|
4268
Forte Biosciences
FBRX
$138M
| $300K | ﹤0.01% |
4,055
-3,083
| -43% | -$228K |
|
4269
Sandstorm Gold
SAND
$3.35B
| $300K | ﹤0.01% |
52,264
| – | – |
|
|
RIVE
4270
DELISTED
Riverview Financial Corporation Common Stock
RIVE
| $300K | ﹤0.01% |
+22,832
| New | +$300K |
|
4271
Barnwell Industries
BRN
$11.5M
| $299K | ﹤0.01% |
98,857
+84,712
| +599% | +$256K |
|
4272
Quantum Computing Inc
QUBT
$2.4B
| $299K | ﹤0.01% |
+48,036
| New | +$299K |
|
4273
Vivos Therapeutics
VVOS
$30.7M
| $298K | ﹤0.01% |
2,954
+1,048
| +55% | +$106K |
|
|
ALNA
4274
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
| $298K | ﹤0.01% |
330,599
+45,032
| +16% | +$40.6K |
|
4275
Urban One Class A
UONE
$71.7M
| $296K | ﹤0.01% |
36,520
-20,533
| -36% | -$166K |
|